Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: Is the crosslinked version more advantageous?

This publication has 24 references indexed in Scilit:

• Clinical impact of serum proteins on drug delivery
  Journal of Controlled Release, 2012
• Protein‐Based Nanomedicine Platforms for Drug Delivery
  Small, 2009
• Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
  Journal of Controlled Release, 2008
• Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone
  International Journal of Pharmaceutics, 2008
• Paclitaxel Encapsulated in Cationic Liposomes Increases Tumor Microvessel Leakiness and Improves Therapeutic Efficacy in Combination with Cisplatin
  Clinical Cancer Research, 2008
• Human serum albumin (HSA) nanoparticles: Reproducibility of preparation process and kinetics of enzymatic degradation
  International Journal of Pharmaceutics, 2008
• Direct comparison of two pegylated liposomal doxorubicin formulations: Is AUC predictive for toxicity and efficacy?
  Journal of Controlled Release, 2007
• Development and characterization of a novel Cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation
  European Journal of Pharmaceutics and Biopharmaceutics, 2005
• Pharmacokinetics of Pegylated Liposomal Doxorubicin
  Clinical Pharmacokinetics, 2003
• Liposomen
  Drugs, 1997